The New York Times COVID “Mystery” solved!
Cases have plunged in India in a few weeks. True
The New York Times reported on July 30, 2021, that this is a mystery with no clear explanation. But, the drop in cases happened right after a new COVID-19 protocol was released in India. The new guideline includes Ivermectin for early treatment — to treat patients with mild symptoms.
The newspaper says a similar drop may now be underway in Britain. False
The drop in the UK is quite different and it isn’t a mystery either. The massive surge in cases was driven by children and young adults. Students were testing themselves two or more times per week. The same child with COVID could be counted multiple times. The last school period went from the end of May up until July 15. The surge in cases started at the end of May and on July 17 cases dropped. The school period and the surge match perfectly.
Hospital admissions keep growing as well as fatalities but still the numbers are small.
Analyses by Juan Chamie
Juan Chamie is a Senior Data Analyst who has been tirelessly researching and spreading the word of ivermectin since early May, 2020. Like the rest of the world, Mr. Chamie closely followed the spread of COVID-19, and his interest in ivermectin was piqued when a doctor in the Dominican Republic used the drug successfully to treat the illness.
Quickly thereafter, a major outbreak in Iquitos, Peru, and local health officials’ successful use of ivermectin to curb the disease, launched Juan’s months-long investigation into widespread efficacy of the drug. Using data as his compass, he showcased his results in stunning data visualizations, and has been using his findings to try to convince health officials and leaders across the world of the positive results of this easily-accessible, highly-affordable drug.
Juan is currently analyzing data of ivermectin intervention all over the globe.
Juan Chamie lives with his wife in Cambridge, Massachusetts.
The FLCCC Alliance has used Chamie’s data analyses with his consent in their Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 and in the Presentation during the FLCCC Alliance News Conference on Dec. 4, 2020, in Houston. We thank Juan for his thorough and important work in proving the efficacy of ivermectin in the prophylaxis and treatment of COVID-19 and for agreeing to use his data analyses in our publications.
Peru
Argentina
Mexico
